The aim of this review was to identify patient-focused interventions that have been trialed to support vulnerable patient populations taking oral anticoagulants (warfarin and the direct-acting oral anticoagulants (DOACs)) such as older persons (65 years and over), those with limited health literacy, and those from culturally and linguistically diverse (CALD) backgrounds. This review also aimed to report on the effects of these interventions on outcomes relevant to the use of anticoagulant therapy. Original articles published between 1 January 1995 and 30 June 2017 were identified using several electronic databases such as Medline, Ovid, Embase, Scopus, Cochrane, and Google Scholar. The following terms were used for the three-tiered search: Tier 1, elderly, aged, older adult, geriatrics; Tier 2, health literacy, literacy, low health literacy, low English proficiency, patient literacy; and Tier 3, ethnicity, ethnic, ethnic groups, CALD, culturally and linguistically diverse, NESB, non-English speaking background, race, racial groups, religion, religious groups, and minority groups. The terms for each tier were combined with the following terms: anticoagulants, anticoagulation, warfarin, apixaban, dabigatran, rivaroxaban, DOACS, new oral anticoagulants, novel oral anticoagulants, patient care, patient knowledge, comprehension, patient education, patient participation, and communication. A total of 41 studies were identified. Most of the interventions identified included older persons taking warfarin who were monitored using the international normalized ratio (INR) and who received patient education. Many interventions reported a significant positive impact on patients' knowledge, reduction in the number of adverse events caused by hemorrhage, and better INR control. More research on patient-focused interventions is needed that includes patients with limited health literacy, those from CALD backgrounds, and family members and caregivers of patients taking oral anticoagulants.
Introduction
Medication-related problems, such as unsafe medication practices and medication errors, are leading causes of avoidable harm in healthcare systems throughout the world and may be serious enough to cause disability or death. 1 Medication problems can occur when patients take high-alert medications, such as oral anticoagulants, which have a high risk of severe harm if used improperly. [1] [2] [3] Vulnerable patient populations, such as older persons, those with limited health literacy, and those from culturally and linguistically diverse (CALD) backgrounds, are at risk of experiencing medication problems for several reasons. Older persons taking anticoagulants are at risk of adverse events such as bleeding because they often have multiple comorbidities, severe chronic kidney disease, agerelated functional and cognitive decline, or polypharmacy, all of which can increase their risk of clinically relevant drug-drug interactions. 4, 5 Patients with limited health literacy are likely to have little understanding of the use of warfarin 6 and may struggle to understand written materials journals.sagepub.com/home/taw Therapeutic Advances in Drug Safety 10 provided to them. 7, 8 This can reduce their adherence and increase the risk of adverse events such as bleeding. 9 In addition, patients from CALD backgrounds may have differing cultural perceptions or beliefs about prescribed treatment. Religious influences, language and communication barriers, inadequate use of interpreters, poor understanding of healthcare services, and socioeconomic barriers can limit their access to the healthcare system. 10 The literature shows that patients from CALD backgrounds require information about medication to help them manage their use of medications. [11] [12] [13] A patient-centered care approach is one way to support these vulnerable patient populations taking oral anticoagulants and to protect them from harm. 14, 15 Several literature reviews have focused on educational, behavioral, and self-monitoring and selfmanagement interventions for patients taking oral anticoagulant therapy. [16] [17] [18] [19] [20] [21] We chose to take a narrative review approach to gather different types of evidence from both qualitative and quantitative research 22 and to synthesize this information to provide a comprehensive overview of this broad area of research. We used this narrative review approach to ensure the inclusion of fulltext articles, published conference abstracts, and studies of populations with limited health literacy and CALD backgrounds. We reasoned that the information gathered from the diverse types of studies of warfarin could be applied to the design of future interventions involving direct-acting oral anticoagulants (DOACs) that are patient focused and cost-effective.
The specific objectives of this review were: 1) to describe the range of interventions developed, implemented, and evaluated to support vulnerable patients using anticoagulant therapies (i.e. warfarin or one of the DOACs); 2) to report on the impact of these interventions on outcomes relevant to the use of anticoagulant therapy.
Definitions

Vulnerable populations
We defined a vulnerable population as those people who are at risk of medication-related problems. 4, 10, 23, 24 Studies that included the following people were included: older persons, those with limited health literacy and those from CALD backgrounds.
Older persons
We defined older persons as those aged 65 years or over. 25, 26 Limited health literacy The World Health Organization (WHO) defines health literacy as 'the cognitive and social skills which determine the motivation and ability of individuals to gain access to, understand and use information in ways which promote and maintain good health'. 27 The articles identified in this review used different tools to measure the level of health literacy. [28] [29] [30] [31] These included The Rapid Estimate of Adult Literacy in Medicine (REALM) tool 32 and the shortened version of the Test of Functional Health Literacy in Adults (S-TOFHLA). 33 Newer tools such as the Health Literacy Questionnaire 34 are available to access health literacy, however, were not identified in this review.
CALD patients
In Australia, CALD has been defined as those people born overseas in countries other than those classified by the Australian Bureau of Statistics as 'main English-speaking countries'. Others terms used to describe CALD include 'ethnic minorities', 10, 13 'multicultural', 'migrant', and 'from a non-English speaking background'. 35 Methods A structured search of the literature was performed as described in the following.
Data sources
The following electronic databases were searched to retrieve original articles, review papers, and other publications published from 1 January 1995 to 30 June 2017: Medline, Ovid, Embase, Scopus, the Cochrane Library, and the search platform Google Scholar. This time frame represents the period after which pivotal trials of anticoagulation therapy for stroke prevention in atrial fibrillation were conducted and published, which lead to an increase in the prescribing of these agents as well
For the Scopus database, because of the number of articles, the term 'older adult' was used from Tier 1, ethnicity from Tier 2, and all terms from Tier 3.
Selection criteria
One author performed the search to identify relevant articles. Duplicates were removed, and the articles based on titles and abstracts were screened. For all articles, (including published conference abstracts), 31, 38 the full-text version was retrieved and assessed according to the objectives of this review. The reference lists of the retrieved articles and review articles were examined manually to identify further relevant studies not identified using the search strategy. The review procedure was verified by the co-researcher.
The studies were selected according to the following criteria: (1) involving a majority of people who were older persons (articles were limited to those including people aged 65 years and over identified using Medline and Embase), limited literacy, from a CALD background, and aged more than 18 years; (2) patient-focused interventions; (3) studies reporting the use of the oral anticoagulants warfarin and DOACs such as apixaban, rivaroxaban, and dabigatran; (4) studies reported in English; (5) original research articles; and (6) articles available in full text.
Case studies and articles without abstracts or full text were excluded. Articles that included programs supporting physicians and patients were excluded to ensure that the outcomes reported in this review reflected the impact of interventions that directly supported only patients. In addition, many studies have addressed the use of anticoagulants through the clinician's lens by focusing on interventions to optimize the use of these agents. Although this focus is important, it only partially considers the barriers to the use of anticoagulants.
What is also needed is a comprehensive range of interventions to support patients' daily use of these agents and their long-term adherence. Although many resources are available in practice, few actually meet the needs of those patients who are most likely to need anticoagulation therapy but who are also more likely to experience difficulties (i.e. older persons, those with low literacy, and those from CALD backgrounds.
Data extraction
The following data were extracted from the included articles: author, publication year, setting, country, title of publication, trial design, type of intervention, subjects (number of patients, mean age in years, ethnicity/race, health literacy), and key findings (( Table 1, Table 2 and Table 3) ).
Results
A total of 41 articles were included in the review ( Figure 1 ). Most patient-focused interventions targeted older persons (n = 37). For older persons, the most common intervention trialed involved monitoring of the international normalized ratio (INR) (n = 20). Other interventions involved patient education and included written information (n = 2), decision aids (DAs) (n = 6), videos (n = 3), pharmacist counseling (n = 1), medication instructions (n = 1), and programs with multiple components (n = 4). Only two • The improvement in patient satisfaction was not significant • Major bleeding at 6 months. Overt bleeding that led to the loss of at least 2.0 units of blood in 7 days or less or was otherwise life-threatening
• Major bleeding was significantly more common at 6 months in the usual care group than in the intervention group (p = 0.0498, log-rank test)
• Death and recurrent venous thromboembolism occurred with similar frequency in both groups at 6 months in the intervention group versus usual care groups (p =
0.2)
• Throughout 6 months, the proportion of total treatment time during which the INR was within the therapeutic range was significantly higher in the intervention group than in the usual care group (56% versus 32%; p < 0.001)
• The proportion of total treatment time during which the INR was within the therapeutic range was significantly higher in the intervention group than in the usual care group (p < 0.001) interventions for patients with limited health literacy and patients from CALD backgrounds were identified.
Studies about DAs included warfarin and the DOACs together, and one study incorporated a video and included the DOAC apixaban. These studies had limitations such as exclusion of nonEnglish-speaking patients, difficulty recruiting warfarin-naïve participants, small sample size, and not being randomized controlled trials (RCTs). 
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The main interventions to support older persons included INR monitoring (Table 1) and patient education through written and unwritten information (Table 2) .
INR monitoring of patients taking warfarin
The INR monitoring of the use of warfarin may occur through self-monitoring or patient self-management (PSM) and is important for minimizing the risk of hemorrhagic or thromboembolic complications. Self-monitoring is defined as the training of a patient to use point-of-care (POC) testing via a portable device to perform the INR test and inform their healthcare provider of the result. The physician or another healthcare provider uses the results obtained by the participant to adjust the anticoagulant dose as required. PSM is defined as the patient obtaining INR values directly according to a predetermined dose-INR schedule and adjusting the warfarin dose independently. 18, 55 This review found that various INR monitoring models were beneficial in supporting older persons. These included POC testing (n = 10) 39,40-48 led by pharmacists in the community [39] [40] [41] and in rural 43 and home [44] [45] [46] settings, along with home self-monitoring (n = 2) 47,48 ; telemonitoring using venipuncture testing (n = 6) 49,50-54 led by a multidisciplinary team, 44 pharmacists, 50,51 and nurses [52] [53] [54] ; and PSM using venipuncture testing (n = 3) through the use of nomograms, 55 a dosing algorithm, 56 or an online messaging system. 57 However, some of these models of INR monitoring were beneficial only for certain patients. POC testing was suitable for patients who had limited access to an anticoagulant clinic, 48 57 who had a preference for PSM over physician management, 55 and who were comfortable changing the warfarin dose on their own. 56 Only two studies were RCTs that found benefits of education, home self-monitoring, 47 and the role of a pharmacist follow-up service after discharge that included home monitoring 44 in supporting older persons. Most of the other studies were prospective or observational.
Decision aids
The most commonly reported patient-focused intervention that included both warfarin and DOACs was the use of decision aids (DAs; n = 6). [58] [59] [60] [61] [62] [63] DAs can support patients by making their decisions explicit, providing information about options and associated benefits/harms, and helping to clarify congruence between decisions and personal values. 17 Three of the six articles identified were RCTs 61-63 (Table 2) .
One prospective study (n = 81) had the objective of validating a DA to assist patients in choosing between antithrombotic agents for AF. 58 This validated DA was unique because it presented and compared information between all antithrombotic treatment options for atrial fibrillation, such as warfarin and DOACs, was accessible for clinical use through a website, and was developed using the standard criteria of the International Patient Decision Aid Standards. 58 It also involved pretesting to refine the DA, which indicates that it was tailored to the needs of older persons. 58 The DA presented descriptions related to atrial fibrillation and charts depicting important outcomes for comparisons between: (1) no treatment, aspirin, and anticoagulants; (2) warfarin versus DOACs; and (3) dabigatran, rivaroxaban, and apixaban. 58 Overall, the DAs were available in a variety of formats such as paper booklets, 58,60 decision board, 59 computerized DA, 63 and a combination of formats, such as a decision booklet with audiotape, 59 ,63 a 29-page paper booklet with a personal worksheet, and a 20-minute audiotape that guided the patient through the booklet and worksheet. 61 One DA contained a graphic presentation of outcome probability data for the benefits and harms as a pie chart or pictogram. 59 
Videos
Three studies trialed the use of videos as a format for educating older persons taking warfarin 65, 66 and the DOAC apixaban. 64 One study (n = 40) showed that, compared with face-to-face counseling, informational videos coupled with teach-back questions significantly reduced pharmacist time spent on anticoagulation counseling on discharge without compromising short-term patient comprehension, primarily in patients with prior warfarin use. However, this study found a nonsignificant reduction in patients using warfarin for the first time. 65 journals.sagepub.com/home/taw 15 Another study reported that the use of narrative evidence in the form of patient anecdotes was more effective than statistical evidence on certain outcomes, such as beliefs about the importance of laboratory testing, and on knowledge when baseline knowledge was included as a covariate. 66 Educational videos that are indication-specific may improve short-term knowledge (less than 6 months). 64 However, the studies involving videos did not specifically target older persons in their inclusion criteria and did not explain whether the target population was involved in the development of the videos. This suggests that the videos may not have acknowledged the needs of older persons and that the videos may not have been tailored to their needs.
Written information
Two studies in the UK 67, 68 showed that patient information booklets significantly improved older person's knowledge, such as the ability to name side effects of warfarin and to describe what would happen to their INR after omitting a dose of warfarin, 67 the target INR range, and factors that may affect INR level. The limitations of one study included a lack of patients' perceptions on the usefulness of the booklet and that only 33 (35.5%) of patients were able to complete the follow-up questionnaire. 68 The studies that described the use of booklets had several limitations. The development of the booklets was not explained, which suggests that the authors did not tailor the booklets according to the needs of the participants. Although one booklet 68 significantly improved patients' knowledge of the target INR and factors that may affect INR levels, it had little effect on awareness of the bleeding risks associated with anticoagulants. In addition, patients' perceptions of the value of the booklets were not determined.
Pharmacist counseling
Before hospital discharge, pharmacists play an important role in educating patients about their medications through counseling. One study highlighted the importance of pharmacists educating patients about the critical information for warfarin counselling and the need for regular counseling sessions. 69 One limitation of this study was its small sample size (n = 22).
Medication instructions
Another intervention involved patients receiving instructions about medication use from either a physician or nurse, plus a pharmacist after the patient had filled the prescription for warfarin. 70 These patients had a reduced risk of experiencing hospitalization because of warfarin-related bleeding over the next 2 years. The instructions may have included statements such as: things the patient should and should not do when taking the medication; written or spoken instructions; and instructions received from the doctor, nurse, or pharmacist. 70 Overall, although most studies targeted older persons, only six studies specifically targeted this population in their inclusion criteria and rationale: two programs, 71, 72 one INR monitoring intervention, 47 two DAs, 59, 60 and a medication instruction intervention. 70 Older persons were targeted because they are at increased risk of unstable control of anticoagulation 47 and warfarin-related bleeding complications 71 or because they are representative of the population with atrial fibrillation for whom anticoagulation is recommended to prevent strokes. 59, 60 Older persons are also at significantly greater risk of an adverse drug event compared with younger patients. 72 One study 70 did not mention the reason for targeting older persons, although it highlighted the importance of patients taking warfarin receiving medication instructions from a physician or nurse and a pharmacist because those patients who could recall receiving instructions had a lower rate of warfarin-related hospitalization for bleeding. 70 These studies did not describe the development of the interventions and therefore may not have tailored the interventions to the needs of older persons.
Programs with multiple components
One RCT 71 evaluated a program with multiple components, including patient education and training to self-monitor their INR levels. Another RCT 73 evaluated a complex educational-behavioral intervention to support older persons taking oral anticoagulants. Another program (n = 97) was unique because it was theory driven and was based on the relevant current literature and clinical guidelines 74 ; it also involved the patients during the development of the intervention and had a multidisciplinary process involving patients, psychologists, and cardiologists. 73 The program was compared with usual care, which comprised a journals.sagepub.com/home/taw
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standard yellow booklet and included an 'expert patient'-focused DVD based on patient narratives, along with an educational booklet, selfmonitoring diary, and worksheet. Critical elements in the development process included the use of clinical guidelines, appropriate theoretical models, patient input, and appropriate evaluation tools. 73, 74 One limitation of this program was that 12 months after initiation of warfarin, there was no significant difference in the time in target INR range (TTR) between the intervention and control groups. This lack of difference suggested that the program needs to be repeated at regular intervals to refresh information and reinforce behavioral changes. 74 Other programs included a patient education campaign that involved tool kits with large print booklets, posters, bookmarks, pamphlets, and postcards. 72 Another program included personalized therapeutic information, including phone calls on days 15, 30, and 45, paper booklet offerings, and website suggestions. 38 Interventions for patients with limited health literacy Hospital pharmacist counseling with a booklet. One study (n = 34) trialed the use of hospital pharmacist counseling and a warfarin booklet 28 ; 39.5% of patients (n = 17) in this study had limited health literacy ( Table 3 ). The intervention significantly improved warfarin knowledge within 24 h of verbal counselling. 28 However, the knowledge score decreased significantly after 28 to 56 days of counseling. 28 Rivaroxaban patient assistance kit. Another study, a prospective RCT (n = 25), trialed the effect of a rivaroxaban patient assistance kit (R-PAK) with pharmacist counseling for patients discharged with rivaroxaban compared with the standard rivaroxaban group who were discharged with no kit. The aim was to determine whether the use of the kit increased proper dose transition and overall patient adherence. Proper transition to daily administration on day 22 did not differ between the groups, and adherence did not differ between the R-PAK patients and those patients taking rivaroxaban with no discharge kit. 31 However, in that study, health literacy was assessed based on a single-item health literacy screening tool. Most patients stated they rarely or never required help to read instructions, pamphlets, or other written materials from their doctor or pharmacy, meaning that their rate of health literacy was high. 31 The authors of these two studies specifically targeted patients with limited health literacy because they are more likely to have little knowledge about warfarin, an increased risk of bleeding complications, and may not understand patient educational brochures about anticoagulants. 28, 31 Furthermore, DOACs such as rivaroxaban have a short half-life, which requires a change in medication dosage and frequency on day 22 to prevent venous thromboembolism. This may increase the risk of patient error, especially for patients with limited health literacy. 31 The development of the visual aid, booklet, and R-PAK was not described, which suggests that these interventions may not have been tailored to the needs of those with limited health literacy despite the intentions of the authors.
A limitation of these health literacy studies was that they assessed health literacy using different tools and that most of the patients had an adequate 29, 30 or high level of health literacy. 31 
Interventions for patients from CALD backgrounds
Two studies showed that the use of a visual aid 29, 30 and a mobile health application 75 supported patients from a CALD background group by improving their anticoagulation control more rapidly than that observed in control subjects 30 and increased their knowledge of warfarin therapy 75 (Table 3) .
Visual aids
Visual aids 29, 30 have been used to specifically target patients from CALD backgrounds and those with limited health literacy. The visual aids were used to overcome potential communication and language barriers in this target group and to thereby reduce or prevent nonadherence and ensure clinician-patient concordance with the prescribed warfarin regimen.
In a prospective cohort study (n = 220), Englishspeaking and Spanish-speaking patients from varied cultural backgrounds were asked to verbally indicate their weekly warfarin regimen and to identify this regimen from a digitized color menu journals.sagepub.com/home/taw 17 of warfarin pills. 29 Health literacy was assessed using the S-TOFHLA, the shortened form of a test of functional health literacy in adults. 33 Another RCT (n = 147) 30 evaluated the use of a computer-generated visual medication schedule of digitized images of the patient's warfarin regimen printed on a 7-day calendar in combination with a brief 2-minute 'teach-back' session. 30 The visual schedule was translated into Spanish and Cantonese. The study found that CALD patients benefitted from the translated texts. Patients were categorized as having regimen concordance if there was no patient-clinician discrepancy in the total weekly dosage of warfarin. 30
Mobile health applications
One study of the use of a mobile health application for patients from CALD backgrounds and older persons found the mobile application may enhance self-management skills in terms of medication adherence and self-care with anticoagulation therapy. 75 These patient groups were specifically targeted because they may struggle following a multicomponent treatment regimen that may affect their diet and activities. In addition, adherence of patients from CALD backgrounds, such as older Hispanic people, has been shown to be poor because of inadequate knowledge about warfarin therapy, especially about Latin foods containing a high amount of vitamin K. 75 This intervention was tailored to the needs of older persons by having a simple layout, large navigation buttons and a component ('Message to tell doctors') to increase effective communication with their doctor on matters such as INR results, medication reminders, and symptom monitoring. 75 It was also tailored to CALD participants by allowing them to invite family members, including grandchildren or children, to the training sessions and by providing a list of foods that Hispanic people commonly eat, along with data from the US Department of Agriculture on the amounts of vitamin K in foods. 75 Interventions that included a combination of patient populations Four studies included patient populations with several characteristics. One study that involved pharmacist counseling included older persons with limited health literacy. 28 Two studies describing the use of visual aids included CALD populations with limited health literacy. 29, 30 One study that evaluated a mobile health application included older English-speaking and Spanish-speaking people. 75 Comparison of the impact of patient-focused interventions on outcomes A variety of outcomes were assessed after the interventions. These included knowledge, anticoagulation control, adverse effects, decisional conflict, mortality, QOL, and patient satisfaction and persistence with warfarin therapy.
Impact on knowledge
Most interventions were effective in improving knowledge. These interventions included DAs, [58] [59] [60] [61] [62] [63] written information, 67,68 a program, 73 a video, 64 patient education by a pharmacist, 46,69 and a mobile health application. 75 Several DAs significantly improved knowledge about warfarin. [58] [59] [60] [61] [62] One RCT (n = 98) conducted in Canada reported significant improvements in the mean knowledge score for atrial fibrillation, treatment options, and outcomes regardless of the format or graphic presentation of the DA. 59 The intervention with the longest follow up was conducted in an anticoagulation clinic (n = 24) and showed that after 6 months of using a written booklet, patients' knowledge about the side effects of warfarin and the consequences of a missed dose of warfarin on the INR increased significantly. 67 In a RCT lasting 6 months (n = 97), the educational intervention comprising a DVD with patient narratives, educational booklet, self-monitoring diary, worksheet, and a group discussion, knowledge scores significantly predicted TTR. 73 An intervention using a mobile health application showed a significant increase in anticoagulation knowledge from the baseline to the 3-month follow-up for participants taking warfarin. 75 An intervention including a video about apixaban produced a significant improvement in knowledge about apixaban from before to immediately after the intervention; however, there was no significant change in knowledge at 1 month after the intervention or at the follow up. The study also found that the scores were less likely to improve in patients who had previously received apixaban or another anticoagulant compared with new patients. 64
journals.sagepub.com/home/taw
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Some of these studies had several limitations. The time frame for the decrease in knowledge retention varied from 28 days 28 to 6 weeks 69 or 3 months. 46 The content of knowledge provided to educate patients and the instruments used to measure knowledge varied between studies, and this may have affected the outcomes. The main topics for patient education included the indications and duration of warfarin use, dosing, administration time and actions in the event of missed doses, target INR range, side effects, interactions with other drugs and herbs, and lifestyle issues such as alcohol and diet. Knowledge improved in several areas, such as the purpose of the medication and the identification of adverse effects, 64, 67, 69 patients' understanding of when to seek emergency attention, 64 management of missed doses, 64, 67 and target INR range. 67 The instruments used for some studies 28, 46, 65, 69 included the Oral Anticoagulation Knowledge test, 76 the Anticoagulation Knowledge Assessment tool, 77 and a tool described by Taylor et al. 78 
Impact on anticoagulation control (INR monitoring)
Most studies that showed a significant improvement in anticoagulation control, as indicated by the TTR, involved POC testing. 40, 43, 44, 47, 48 One unique finding from one RCT (n = 125), 47 was the benefits of education alone in improving TTR. Other interventions that found a significant improvement in anticoagulation control included a written information booklet, 67 programs, 71, 73 and a telemonitoring service led by pharmacists. 50 Another RCT (n = 147) showed that patients using a computer-generated visual medication schedule achieved anticoagulation control more rapidly than control subjects. 30 The benefit of the intervention was significant for patients with baseline regimen discordance but not for those with baseline concordance. 30 
Impact on adverse events such as hemorrhagic or thromboembolic complications
Two studies involved a post-discharge home-based service by a pharmacist, including POC INR monitoring, warfarin education, 44, 45 and a home medicines review. 45 These interventions reduced the rate of adverse effects of warfarin. In one randomized controlled cohort study (n = 129), inclusion of a post-discharge service was associated with significantly lower rates of combined major and minor hemorrhagic events to 90 days post-discharge and at 8 days post-discharge compared with usual care (n = 139). In addition, the rate of combined hemorrhagic and thrombotic events to day 90 was also significantly lower, and persistence with warfarin therapy improved significantly. The second open-label RCT (n = 128) showed a significantly lower rate of bleeding events 3 months after discharge in the intervention group compared with patients in usual care. Other studies included two PSM programs, 55,57 POC testing, 47, 48 telemonitoring, 50,51 and a multicomponent program that included patient education about warfarin, training to increase patient participation in their care, self-monitoring of prothrombin time using a portable home monitor, and guideline-based management of warfarin dosing. 71 
Impact on decisional conflict
Most of the DAs assisted older persons with becoming more confident and comfortable with their treatment decision. [58] [59] [60] 62, 63 However, in a recent Cochrane review, 19 data from two trials were pooled, and the random-effects analysis favored usual care in terms of reducing decisional conflict. 61, 62 Decisional conflict has been measured using a variety of tools, which makes it difficult to compare the outcomes. In one review, 79 some of the studies reported decisional conflict outcome using the p value, [61] [62] [63] whereas other studies reported no p value. 59, 60 In contrast to other reviews, 19, 79 our review found one new study on a DA. 58 This study reported a low decisional conflict score of 7.2 (SD 10.8) on a scale of 1 to 100, which suggested that participants felt informed, clear about their values, supported and certain when making a decision. 58 Another finding of this study was that there was no significant correlation between the years of education and total Decision Conflict Scale score. 58 In addition, our review included one study 63 that was excluded from a meta-analysis 19 because it did not have a usual care arm. This study found a significant decrease in decisional conflict in the computerized decision aid group immediately after a shared decision-making clinic compared with the evidence-based paper guidelines applied as direct advice.
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Impact on mortality and quality of life Three studies measured mortality and showed no impact on mortality compared with the control group or comparison group. 45, 48, 71 Three studies 47, 48, 73 measured QOL as an outcome. One program 73 showed that QOL increased in the intervention group at the 1-month follow up but not at 12 months. The second study 48 showed small but significant improvement in QOL at the 2-year follow up only in the patient group that undertook home monitoring with the self-testing. The third study 47 showed no change in QOL apart from the emotional role limitation (i.e. limitation in usual role activities because of emotional problems), however, the authors stated that this result was probably due to chance. 41 and rural pharmacy settings, 42 and by a multidisciplinary telemonitoring service. 49 The patients in these studies were satisfied with the accessibility of the service, 41 convenience, 41 time saved, immediacy of the blood test results and dose, 41, 49 and monitoring service by a pharmacist. 39, 42 Patients were also satisfied with the DAs 58-60 and a video about apixaban. 64 Older participants and those from CALD backgrounds reported they were generally satisfied with the intervention using a mobile health application because of its ease of use and usefulness. 75 Beliefs about medication and persistence with warfarin therapy. In a study of older persons, the group given a theory-driven educational intervention group was significantly more likely to view medication as less harmful than the usual care group, and patients' perceptions of general harm predicted TTR at 6 and 12 months. 73 In addition, persistence with warfarin therapy improved significantly in patients using a collaborative homebased, post-discharge warfarin management service 45 (n = 129).
Verbal and visual concordance, and patient-provider concordance. CALD patients and patients with limited health literacy were categorized as having verbal concordance if there was no patient-clinician discrepancy in the total weekly dosage of warfarin when the patient verbalized the regimen.
Patients were categorized as having visual concordance if there was no patient-clinician discrepancy in the total weekly warfarin dosage when the patient identified the regimen from the digitized pill menu or a visual aid. 29 In this study that was conducted in an anticoagulation clinic at a San Francisco hospital, shifting from verbal to visual modes was associated with greater patient-provider concordance across all patient subgroups and especially for those with communication barriers such as Cantonese speakers. Clinician-patient discordance regarding the patients' warfarin regimen was common, but occurred less frequently when patients used a visual aid. 29 Another study conducted in the USA involved patients of various ethnicities (n = 147, Asian (40%), White (31%), Hispanic (17%), and Black (12%)) with poor anticoagulant control, most of whom had limited health literacy. Use of a visual medication schedule combined with brief counselling reduced the time to anticoagulation control. 30 Overall, most interventions did not specifically seek to include vulnerable patient groups as part of their recruitment process. Most of the interventions were not tailored to address the needs of each vulnerable patient group, and most of the authors failed to acknowledge the needs of each group or to describe the development of the interventions. Nonetheless, these studies were included according to this review's search criteria because we felt that the lessons learned from their strategies could be applied to vulnerable patient groups in future studies.
Only a few interventions specifically targeted vulnerable patient populations based on the inclusion criteria and rationale of their studies. Of these studies, only one described how the intervention was developed and considered the participants' needs by tailoring the intervention to address them. 75 The interventions that specifically targeted older persons included two programs 71, 72 ; one INR monitoring intervention 47 ; decision aids 59, 60 (one of which ensured that at least half the sample would be 65 years or older 60 ); and a mobile health application that included participants who were 55 years and older. 75 Other interventions specifically targeted patients with limited health literacy; these included pharmacist counselling with a booklet 28 and a R-PAK. 31 Visual aids 29, 30 specifically targeted patients with limited health literacy and those from a CALD background. In addition, the mobile health Therapeutic Advances in Drug Safety 10 application 75 also specifically targeted both older persons and patients from CALD backgrounds.
Discussion
This review has described a range of interventions to support vulnerable patient groups taking anticoagulants such as warfarin or a DOAC and identified the outcomes of these interventions when used with anticoagulant therapy. This review has revealed several important findings.
We found that more interventions had been trialed to support older persons compared with those with limited literacy and from CALD backgrounds. Some of these interventions were comprehensive multimodal programs that were successful. By contrast, a significant finding of this review was that fewer studies have focused on supporting patients with limited health literacy and patients from CALD backgrounds; such studies were also simpler and, in most cases, unidimensional.
Moreover, it was difficult to determine which intervention was the best because of differences in methodology. Some of the interventions differed in their advantages and disadvantages and were suitable for certain patients only.
Another interesting finding was that few interventions specifically targeted vulnerable patient groups in their inclusion criteria and rationale. We identified only six studies 47, 59, 60, [70] [71] [72] describing interventions that specifically targeted older persons and two studies of interventions that specifically targeted those with limited health literacy. 28, 31 The findings from one study 28 highlight the importance of assessing health literacy because of the positive correlation between health literacy and warfarin knowledge. This relationship between health literacy and knowledge was also highlighted in one study of patients with hypertension. 80 The authors concluded that it is important to ensure health education interventions are literacy sensitive because patient knowledge can link health literacy to self-efficacy, self-care, and health outcomes for patients. 80 Only three studies of interventions have specifically targeted several vulnerable patient populations at the same time, such as patients from CALD backgrounds and older persons with chronic diseases who were taking warfarin 75 or patients from CALD backgrounds and those with limited health literacy. 29, 30 These findings suggest that there is a need for more interventions that specifically target vulnerable patient populations.
This review also identified studies describing interventions that did not specifically target vulnerable patient populations groups; however, we included these according to our search criteria. The advantage of some of these reports was that they described how the interventions were developed according to patients' needs, meaning that they were tailored to address those needs. For example, a paper that describes a unique and successful multicomponent program 73 revealed how it was developed using critical elements such as patient input to tailor it to the needs of older persons. The beneficial impact of this program on outcomes such as knowledge and anticoagulation control suggest that future programs to support vulnerable patient groups should be developed based on a similar process, albeit with regular and long-term follow up and repetition at regular intervals.
Another program provided personalized therapeutic information that supported older persons and found improved drug persistence with the DOAC rivaroxaban. This result may have occurred because the program prevented lesscompliant patients from stopping taking DOACs for futile reasons. The authors suggested that these patients should be the target of educational programs. 38 This review also identified a DA that was unique because it included all antithrombotic choices (i.e. warfarin and the DOACs) and was tailored to the needs of older persons. 58 The advantages of including all treatment choices are that the DA can assist patients who may have felt overwhelmed by having to decide on one treatment and it allows older persons to become engaged in shared decision-making with their doctor to help them select the most suitable anticoagulant in a systematic way, in alignment with their values and preferences. 81 Similar to another review, 17 we found that DAs improved older persons' knowledge about oral anticoagulants, helped participants feel informed and clear about their values and supported when making a decision. The implications of our findings suggest that future DAs should be developed in a similar way with the same features. However, although studies of DAs were beneficial in improving older persons' knowledge of the oral anticoagulants journals.sagepub.com/home/taw 21
and confidence with their treatment decisions, one study reported a limitation: when the names of the treatment options were revealed, it was clear that some participants had chosen a lesseffective treatment (aspirin instead of warfarin). 59 The authors of this study suggested that, to optimize treatment, it is important for clinicians to allow patients time to express their preferences and rationale for treatment options at the time of prescribing. 59 Similar to the unique DA, this review also found a paper that described a video that included the DOAC, apixaban, to support older persons. 64 The advantages of videos in supporting older persons are the ability to increase patients' knowledge about oral anticoagulants, to strengthen their beliefs in the importance of laboratory testing and the benefits of taking warfarin, to convey a large amount of complex information, to be watched several times at home with the family, and to be helpful to those patients who have difficulty reading written material, such as people with limited health literacy and from CALD backgrounds who cannot read English. 66 Considering similar findings noted in another review, 21 we suggest that videos should incorporate narrative evidence such as patient anecdotes into physician-patient dialogues or educational materials to increase the effectiveness of the message. 66 One of the potential problems of using a video is that knowledge may not be retained beyond 1 month, which is problematic because many patients, such as older persons with chronic atrial fibrillation, need to take oral anticoagulants beyond 1 month. In addition, patients may not be motivated or empowered to watch the video again after discharge from the hospital. 64 Several INR monitoring models were also identified to support older persons who take warfarin. The advantage of using POC INR measuring devices to support older persons in self-testing compared with venous plasma testing is that it allows for more frequent home monitoring of the INR through weekly self-testing. 47 This, in turn, can lead to better anticoagulation control, better dosage advice, and improved concordance. 47 POC INR monitoring promotes patient engagement in their own care and may improve clinical outcomes because out-of-range INR values can be identified and treated more quickly. 48 However, there are some disadvantages in using POC INR monitoring devices, including the resources required for extensive training of nurse clinicians or specialized physicians, cost of test strips, fear of self-testing or needles, and difficulty learning the technique to perform the test. 47, 55 Another model that used technology to support older persons with INR monitoring was telephone anticoagulation services. Studies using this model reported benefits such as accessibility, convenience, follow up via the telephone for patients unable to present in person to an anticoagulation clinic, patient satisfaction, and improved clinical outcomes such as fewer anticoagulation complications. 51 A telephone service also allows for a large number of patients to be managed by a few anticoagulation providers over a wide geographic area, 50 in the home setting, 54 and in the anticoagulation clinic setting. 51 However, some of these studies were limited because they were not RCTs and did not measure outcomes such as medical costs. 49, 51 In some PSM models using venipuncture, older persons were able to review their INR laboratory results on the same day the test was performed and communicate with healthcare practitioners using a secure online messaging system, My Health Manager. 56, 57 These models have several advantages: the prompt receipt of INR results, unlike in other studies, in which INR results were communicated to patients in person or via mail 55 ; no additional costs for finger-stick monitoring devices and testing strips; and no need to acquire the skill necessary to perform finger-stick INR tests. 57 Another finding of our review was the beneficial role of multidisciplinary teams and allied health professionals in supporting older persons across different healthcare settings and during the transition of care between settings. Examples include pharmacist-led INR monitoring in collaboration with general practitioners, 44, 45 post-discharge warfarin services, and pharmacist-led education 69 during the transition of care from the hospital to the home setting. The advantage of using pharmacists for INR monitoring and patient education is that they are conveniently located in a variety of healthcare settings such as the community, hospital, and home, and during transitions of care, which can optimize patient safety. 47 and those limited by physical disability and geographic distance, 48, 51 such as people in rural or remote settings 42 who are unable to wait for a face-to-face visit and INR blood withdrawal in an anticoagulation clinic. 51 In the study of a venipuncture PSM model, patients needed to have access to online software such as My Health Manager. 56 Overall, these findings highlight the important role of a caregiver and the accessibility and convenience of managing INR monitoring using certain models such as those applicable to the home setting, which could be useful for older persons with limited mobility or transportation problems. 36 Other interventions that supported older persons involved written information in the form of patient information booklets. 67, 68 The lack of impact of one booklet on certain aspects of anticoagulants and of input from patients about their perceptions of the value of the booklets 68 suggests that written information alone is insufficient to increase patients' knowledge of anticoagulants and that, ideally, patients should have input into the development of a resource. A similar result was found in another study, in which patients and/or their caregivers viewed the supply of a booklet as inadequate and thought both verbal and written information were equally important. 82 These findings are important because a lack of knowledge regarding warfarin can influence anticoagulation control and the rate of adverse outcomes. 21 Another important finding of this review was that the beneficial impact of several interventions on outcomes, such as knowledge, anticoagulant control (TTR), and decisional conflict, were short term and the length of follow up was brief. These findings highlight the importance of regular and long-term follow up and the need to repeat interventions at regular intervals.
Finally, only two interventions, a mobile health application 75 and a multicomponent program, 74 were tailored to the needs of the vulnerable patient groups. These had a beneficial impact on outcomes such as improved knowledge, better anticoagulation control, and improved beliefs about medication. By contrast, several interventions were not tailored to the vulnerable patient groups and used a variety of INR monitoring models, DAs, videos, and booklets; however, they still had a positive impact on the same outcomes. These findings suggest that tailored and nontailored information can be used to support vulnerable patient populations to optimize patient outcomes. If tailored information is developed, healthcare professionals should be trained in individualizing interventions and responding to patients' specific needs. Healthcare professionals should also learn how to provide a suite of resources that are culturally relevant 7 or adopt a culturally competence approach 83 and to consider each patient's health and computer literacy. 75, 84 Limitations There are several limitations of this review. We excluded non-English language papers, selected only full-text articles, and set an age limit of 65 years for older persons and included only studies in which the majority of participants were over 65 years of age. Setting a lower age limit may have incorporated more articles. The articles were selected by one reviewer who could have introduced some bias towards the results.
This review shows that several studies used different tools to measure warfarin knowledge 28, 46, 65, 69 and health literacy. [28] [29] [30] In addition, the studies differed on a number of aspects: methodology, inclusion and exclusion criteria, sample size, setting, duration and type of study (i.e. only eight studies were RCTs), 30, 47, 44, [61] [62] [63] 71, 73 follow up, patient medical conditions, and inclusion of participants with a history of taking warfarin or a DOAC or those just starting medication. These differences made it difficult to compare the clinical outcomes across the trials and limited the generalizability of the results to other settings and countries. In addition, for two studies, it was difficult to determine the effectiveness of each component of the programs. 71, 72 Future research Future research is needed to develop patientfocused interventions that target patients from CALD backgrounds and those with limited health literacy who are taking oral anticoagulants, and to include caregivers and family members. To optimize the treatment of these patient groups, journals.sagepub.com/home/taw 23 healthcare professionals should be trained in developing interventions that are literacy sensitive and culturally appropriate. Other strategies that could be trialed for patients with limited health literacy taking oral anticoagulants may include the use of plain language and teach-back by providers, 85 involvement of consumers when developing materials to ensure understanding of patient information, 86 and clearly presented health educational materials and visual aids. 87 For patients from CALD backgrounds taking oral anticoagulants, other strategies that could be explored include multilingual resources and staff, 13 encouraging patients to ask questions, 88 development of culturally appropriate information, 7 providing interpreters and bilingual-link workers, and using pictorial flashcards. 10 More studies are also required to determine whether interventions that specifically target vulnerable patient populations by acknowledging their needs and being tailored lead to better patient outcomes compared with interventions that are not customized. Larger RCTs are needed of interventions that include all the antithrombotics, use technology such as mobile health applications, and involve multidisciplinary and multicomponent programs with critical elements such as patient input and regular postintervention follow up to achieve a long-lasting impact on patient outcomes.
To enhance knowledge retention of information by vulnerable patients, who are often prone to recent memory loss, a repeated interactive session using text messaging and other smart phone applications such as FaceTime could be studied. Future studies should also ensure that healthcare professionals are trained in individualizing interventions and responding accordingly. In addition, future interventions should consider exploring patient outcomes such as mortality, QOL, and adherence, and their cost-effectiveness. Finally, further research is required for standardizing information about oral anticoagulants and the tools used to measure health literacy and knowledge about anticoagulant use.
Conclusion
Although most of the interventions trialed supported older persons, only a few specifically targeted them. This review identified a major gap in the literature showing that limited interventions have been trialed to support patients from CALD backgrounds and those with limited health literacy. Further research is needed to include patients with limited health literacy and those from CALD backgrounds as well as family members and caregivers of patients taking oral anticoagulants. It may be advantageous to determine whether patient outcomes differ between tailored and nontailored interventions. Future interventions should explore patient outcomes fully, such as mortality, quality of life and adherence, and the cost-effectiveness of interventions.
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